Keeping progress in perspective — a message to Prof. Alan Ashworth

With the publication of data about enzalutamide in the New England Journal of Medicine last week, Professor Alan Ashworth, the head of the Institute for Cancer Research (ICR) in the UK, proclaimed “a golden age in prostate cancer drug discovery.” … READ MORE …